Disruption of Redox Balance Enhances the Effects of BRAF-inhibitors in Melanoma
Ontology highlight
ABSTRACT: Specifically, we report that drug-insensitive melanoma cells can maintain higher levels of antioxidant metabolites to withstand the lethal effects of drugs. By extending our analysis to other melanoma subtypes in the TCGA, we show that elevated redox capacity could indeed be a general feature of melanoma. Our results suggest that redox vulnerabilities could be exploited for therapeutic benefits and identify unsuspected combination targets to enhance the effects of BRAFi in pan-melanoma.
ORGANISM(S): Human Homo Sapiens
TISSUE(S): Tumor Cells
DISEASE(S): Cancer
SUBMITTER: Simona Codreanu
PROVIDER: ST001339 | MetabolomicsWorkbench | Tue Mar 31 00:00:00 BST 2020
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA